This investigation aims to systematically elucidate the biological roles and underlying molecular mechanisms through which FBXO10 regulates HCC pathogenesis, ultimately seeking to identify novel therapeutic strategies for HCC management. This evidence concerns the gene FBXO10 and hepatocellular carcinoma.